
Bioorganic and Medicinal Chemistry Letters p. 881 - 886 (1997)
Update date:2022-08-04
Topics:
Peglion, Jean-Louis
Vian, Joel
Goument, Bertrand
Despaux, Nicole
Audinot, Valerie
Millan, Mark J.
Starting from the structure of the preferential D3 antagonist S 14297 (1), we have prepared a series of cis and trans tetracyclic derivatives of general formula I in order to improve potency and selectivity for D3 receptors. The trans oxazino derivative 2c, showed slightly increased affinity at D3 receptors and double the selectivity for D3 over D2 receptors, in comparison to S 14297. Cis derivatives and compounds where R1 is aralkyl were totally devoid of activity.
View MoreWUXI KINGHAN BIO-MEDICAL&CHEMICAL INC.
Contact:13861062998
Address:Room 1316,No.1619 Huishan Avenue,Wuxi,China
website:http://www.josunpharma.com
Contact:+86-311-80715268 80766839
Address:No.39, Zhaiying Street, Shijaizhuang,Hebei,China
Contact:+86-21-38228826
Address:Room 505 Building 2, No 3377 Kangxin Highway, Shanghai, Republic China
Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)
Contact:+86-523-86818997
Address:Taizhou,Jiangsu Province,CHINA
Jiangsu Institute of Ecomones Co., Ltd
website:http://www.jsmone.com
Contact:+86-519-82821700
Address:95 Huanyuan N. Road, Jintan, Jiangsu, China
Doi:10.1016/S0014-827X(99)00017-8
(1999)Doi:10.1016/j.poly.2010.12.049
(2011)Doi:10.1016/j.tetlet.2008.03.138
(2008)Doi:10.1039/DT9900002321
(1990)Doi:10.1002/ardp.200400884
(2004)Doi:10.1016/j.bmcl.2011.02.058
(2011)